Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, 9609 Medical Center Drive, 3E218, Rockville, MD, 20850, USA.
School of Community and Global Health, Claremont Graduate University, Claremont, CA, USA.
J Cancer Surviv. 2023 Oct;17(5):1445-1451. doi: 10.1007/s11764-022-01180-5. Epub 2022 Feb 11.
Although improvements in breast cancer detection and treatment have significantly increased survival, important questions related to breast cancer risk, prognosis, and survivorship remain. This brief report describes the Health of Women (HOW) Study® methodology and characterizes the participants who completed the My Health Overview and My Breast Cancer modules.
The HOW Study® was a collection of cross-sectional, web-based modules designed to survey a large number of participants with and without breast cancer.
A total of 42,540 participants completed the My Health Overview module, of whom 13,285 (31.2%) reported a history of breast cancer. The majority of participants were white (94.3%), female (99.5%), married (74.1%), college educated (73.2%), post-menopausal (91.1%), parous (68.8%), and reported breastfeeding their children (56.0%). A total of 11,670 participants reported a history of breast cancer in the My Breast Cancer module. The majority of survivors reported on their primary breast cancer and were diagnosed over the age of 40 years (83.5%), had either Stage I or Stage II breast cancer (63.1%), and were treated with surgery (98.8%), radiation (64.8%), and/or chemotherapy (62.3%).
The HOW Study® provides an innovative framework for collecting large amounts of epidemiological data in an efficient and minimally invasive way. Data are publicly available to researchers upon request.
The HOW Study® can be leveraged to answer important questions about survivorship, and researchers are encouraged to utilize this new data source.
尽管乳腺癌检测和治疗的改进显著提高了生存率,但与乳腺癌风险、预后和生存相关的重要问题仍然存在。本简要报告描述了妇女健康(HOW)研究®的方法,并描述了完成“我的健康概述”和“我的乳腺癌”模块的参与者的特征。
HOW 研究®是一系列横断面、基于网络的模块,旨在调查大量患有和不患有乳腺癌的参与者。
共有 42540 名参与者完成了“我的健康概述”模块,其中 13285 名(31.2%)报告有乳腺癌病史。大多数参与者为白人(94.3%)、女性(99.5%)、已婚(74.1%)、大学学历(73.2%)、绝经后(91.1%)、多产(68.8%),并报告过母乳喂养孩子(56.0%)。共有 11670 名参与者在“我的乳腺癌”模块中报告了乳腺癌病史。大多数幸存者报告了其原发性乳腺癌,且诊断年龄超过 40 岁(83.5%),乳腺癌分期为 I 期或 II 期(63.1%),并接受了手术(98.8%)、放疗(64.8%)和/或化疗(62.3%)。
HOW 研究®提供了一种创新的框架,以高效、微创的方式收集大量流行病学数据。数据可根据请求向研究人员公开。
HOW 研究®可用于回答与生存相关的重要问题,鼓励研究人员利用这一新的数据来源。